檢索結果 - Afshin Eli Gabayan
- Showing 1 - 3 results of 3
-
1
Extended follow‐up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma 由 Sundar Jagannath, Brian G.M. Durie, Jeffrey L. Wolf, Elber S. Camacho, David Irwin, Jose Lutzky, Marti McKinley, Phyllis Potts, Afshin Eli Gabayan, Amitabha Mazumder, John Crowley, Robert Vescio
出版 2009Artigo -
2
ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM THE MA... 由 Mohamad Mohty, Michael H. Tomasson, Bertrand Arnulf, Nizar J. Bahlis, Martin Prince, Rubén Niesvizky, P Rodrgue-Otero, J Martine-Lopez, Guenther Koehne, Yogesh Jethava, Afshin Eli Gabayan, Don A. Stevens, Ajay K. Nooka, Noopur Raje, S Iida, Eric Leip, U. Conte, Akos Czibere, Andrea Viqueira, Vivian Blunk, Alexander M. Lesokhin
出版 2023Artigo -
3
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results 由 Alexander M. Lesokhin, Michael H. Tomasson, Bertrand Arnulf, Nizar J. Bahlis, H. Miles Prince, Rubén Niesvizky, Paula Rodríguez‐Otero, Joaquín Martínez‐López, Guenther Koehne, Cyrille Touzeau, Yogesh Jethava, Hang Quach, Julien Depaus, Hisayuki Yokoyama, Afshin Eli Gabayan, Don A. Stevens, Ajay K. Nooka, Salomon Manier, Noopur Raje, Shinsuke Iida, Marc S. Raab, Emma Searle, Eric Leip, Sharon T. Sullivan, Umberto Conte, Mohamed Elmeliegy, Akos Czibere, Andrea Viqueira, Mohamad Mohty
出版 2023Artigo
相關主題
Adverse effect
Chemotherapy
Gastroenterology
Internal medicine
Medicine
Surgery
Astrobiology
Multiple myeloma
Neutropenia
Physics
Refractory (planetary science)
Anemia
Bortezomib
Cancer
Chimeric antigen receptor
Clinical endpoint
Clinical trial
Cytokine release syndrome
Dexamethasone
Discontinuation
Dosing
Immunotherapy
Lenalidomide
Oncology
Progressive disease
Regimen